Verrica Historical Cash Flow
| VRCA Stock | USD 0.43 0.01 2.27% |
Analysis of Verrica Pharmaceuticals cash flow over time is an excellent tool to project Verrica Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Sale Purchase Of Stock of 23.3 M or Stock Based Compensation of 5.9 M as it is a great indicator of Verrica Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Verrica Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Verrica Pharmaceuticals is a good buy for the upcoming year.
Verrica |
About Verrica Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Verrica balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Verrica's non-liquid assets can be easily converted into cash.
Verrica Pharmaceuticals Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Verrica Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Verrica Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Verrica Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Verrica Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.At present, Verrica Pharmaceuticals' Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Total Cashflows From Investing Activities is expected to grow to about 65.3 M, whereas Sale Purchase Of Stock is forecasted to decline to about 23.3 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 302K | 362K | 27K | 25.7K | Depreciation | 718K | 836K | 1.3M | 1.3M |
Verrica Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Verrica Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Verrica Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 423K | 453K | 28.7M | 26.9M | 30.9M | 23.3M | |
| Investments | (1.9M) | 86K | 54.5M | 6.6M | (19K) | (20.0K) | |
| Change In Cash | 1.4M | 5.1M | 18.5M | 35.3M | (23.2M) | (22.1M) | |
| Stock Based Compensation | 9.8M | 6.1M | 5.0M | 14.4M | 7.2M | 5.9M | |
| Free Cash Flow | (31.7M) | (28.5M) | (19.0M) | (38.9M) | (61.0M) | (57.9M) | |
| Change In Working Capital | 1.6M | (535K) | (1.8M) | 9.9M | 2.0M | 1.3M | |
| Begin Period Cash Flow | 9.2M | 10.7M | 15.8M | 34.3M | 69.5M | 73.0M | |
| Total Cashflows From Investing Activities | 26.0M | (3.6M) | (998K) | 54.0M | 62.1M | 65.3M | |
| Other Cashflows From Financing Activities | 772K | 558K | (17K) | (169K) | 155K | 147.3K | |
| Depreciation | 229K | 472K | 718K | 836K | 1.3M | 1.3M | |
| Capital Expenditures | 1.5M | 883K | 302K | 362K | 27K | 25.7K | |
| Total Cash From Operating Activities | (30.2M) | (27.6M) | (18.7M) | (38.6M) | (60.9M) | (57.9M) | |
| Change To Operating Activities | (2.0M) | 2.0M | (532K) | (975K) | (877.5K) | (833.6K) | |
| Net Income | (42.7M) | (35.1M) | (24.5M) | (67.0M) | (76.6M) | (72.8M) | |
| Total Cash From Financing Activities | 35.2M | 33.6M | (16.9M) | 74.2M | 37.7M | 33.8M | |
| End Period Cash Flow | 10.7M | 15.8M | 34.3M | 69.5M | 46.3M | 25.1M | |
| Other Cashflows From Investing Activities | (221K) | (201K) | (180K) | 8K | 9.2K | 9.7K | |
| Change To Netincome | 3.3M | 10.6M | 7.5M | 6.8M | 7.8M | 4.8M | |
| Change To Liabilities | 12K | (338K) | 205K | (593K) | (533.7K) | (507.0K) | |
| Other Non Cash Items | 940K | 1.4M | 1.9M | 3.3M | 5.2M | 5.5M | |
| Cash And Cash Equivalents Changes | (1.0M) | 1.4M | 5.1M | 18.5M | 21.3M | 22.4M | |
| Cash Flows Other Operating | (1.5M) | 1.7M | (512K) | (937K) | (1.1M) | (1.0M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets | Return On Equity |
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.